Check out your Company Bowl for anonymous work chats.
Our Chief Financial Officer, Renée Galá, sat down with Jenna Fisher, author of "To The Top," to discuss Jazz Pharmaceuticals’ culture and important topics including gender parity and our flexible work policies. Read the article below to learn more about the steps we are taking to make Jazz a great place to work by creating a supportive environment where all employees are empowered to contribute and succeed, infusing innovation into how we deliver for patients.
Jazz Pharmaceuticals on LinkedIn: Listening, data, and flexibility are the keys to one company's unexpected...
Our 2022 Corporate Sustainability and Social Impact (CSSI) Report is now live here: https://lnkd.in/eVGx6V3D.. We are committed to maximizing our positive impact on our people and society while ensuring we minimize Jazz’s impact on the environment. Made up of four key pillars, our CSSI approach will support us in delivering for our Patients, People, Communities and the Planet, and will help guide us toward achieving our Vision 2025.
Supporting #mentalhealth for our people at Jazz is an important element of how we define being a great place to work. We want employees to feel valued and we believe in caring for their financial, physical, mental and emotional health and well-being. As we honor #WorldMentalHealthDay and this year’s theme of “Mental Health is a Universal Human Right,” Jazz’s Nina Russell shares her thoughts on how Jazz helps support employees’ mental health.
In our pursuit of scientific expansion, we are excited to share a new episode of #PioneeringPathways, our science-focused series exploring the innovative research behind our pipeline. Watch the latest episode to learn about our investigation into the mechanism of action behind FAAH inhibitors and its potential to address the underlying pathophysiology of post-traumatic stress disorder (#PTSD).
Jazz Pharmaceuticals on LinkedIn: Unique Pathways in Post-Traumatic Stress Disorder | Jazz Pharmaceuticals
Post-traumatic stress disorder (#PTSD) is a common psychiatric condition that affects individuals around the world. Up to 6.1% of Americans who experience a traumatic event in their lifetime will develop PTSD. In support of #MentalHealthAwarenessMonth, learn how we’re expanding our research to address the unmet need for people living with mental health conditions like PTSD.
Jazz Pharmaceuticals on LinkedIn: Exploring New Treatment Pathways for Post-Traumatic Stress Disorder | Jazz...
Shining a Light on the Importance of Caregiving Receiving a diagnosis of any kind has implications not just for the person on the receiving end, but also for their family, friends and the people closest to them. A person’s diagnosis and resulting treatment can affect the way they are impacted by everyday life and may lead to them requiring additional support and care from their family of kin, family of choice or friends.1 Many of the diseases Jazz focuses on are lifelong and profoundly disruptive to a person’s everyday life, therefore requiring the additional support of a caregiver.
Shining a Light on the Importance of Caregiving | Jazz Pharmaceuticals
As part of our continued #DEIB commitment, we are dedicated to prioritizing and supporting LGBTQ+ inclusion within our company and our communities. This week, our employees at #SLEEP2023 wore #PrideMonth pins to demonstrate their support for the community and promote inclusivity at the meeting. We recognize that fostering a diverse and inclusive culture takes ongoing effort and we remain committed to furthering our goals to ensure that we support all backgrounds across our company and within our leadership.
Jazz Pharmaceuticals on LinkedIn: #PrideMonth2023
Jazz Pharmaceuticals' EVP and Chief Legal Officer Neena Patil recently sat down with Taren Grom from PharmaVoice for a new episode of the Woman of the Week podcast to discuss her passion for law and healthcare, her role at Jazz and what inspires her when it comes to social impact and sustainability. Click the link below to listen!
Jazz Pharmaceuticals on LinkedIn: Woman of the Week: Jazz Pharmaceuticals' Neena Patil
Jazz Pharmaceuticals has been selected as a finalist for a 2023 #ASAPAward in three categories – Innovative Best Alliance Practice and Individual Alliance Excellence for Emerging Alliance and Longstanding Alliance! We are committed to the value and investment in strategic alliance management and are grateful to be recognized within a competitive pool of nominees.
Jazz Pharmaceuticals on LinkedIn: #asapaward
Guided by the patient voice and science, we're expanding our #neuroscience pipeline to enter new neurological and psychiatric disease areas with significant unmet patient need. Jazz EVP and Global Head of Research & Development, Robert Iannone, discussed our latest advances in the neuroscience frontier with STAT News. #AANAM https://lnkd.in/d5XS7g-W
Jazz Pharmaceuticals on LinkedIn: #neuroscience #aanam